Perkant Tech, inventors of a leading AI-Enabled Med-tech Multi-disease Prognostic Health Platform, has raised INR 6.6 Crore in a seed funding round led by YourNest Venture Capital. This round includes contributions of INR 5 crore from YourNest, INR 1 crore from the Government of India’s Atal New India Challenge (AIM, Niti Aayog), INR 35 lakh from Villgro Foundation, and INR 25 lakh from the accelerator Sanchi Connect who partnered with YourNest in its Velocity fast-track funding program.

This investment will enable Perkant Tech to enhance its AI-powered prognostic technology, accelerate the R&D efforts and support market expansion, customer acquisition strategies as the company gears up for its commercial launch following successful pilots with world-class partners. Additionally, the funds will also be allocated towards technology upgrades and software development to ensure seamless integration, real-time updates, and personalized health insights, preparing the company’s solutions for widespread adoption.

Perkant Tech holds a granted Indian patent (Application: 526020) and a pending U.S. patent (Application: 18/033,887) for an advanced apparatus designed to measure and acquire distress data from the human body, encompassing both psychological and physiological indicators. Aligned with the government’s National Digital Health Mission (NDHM), Perkant Tech’s integrated platform of measures, tracks and analyzes essential health vitals, redefining primary and preventive care delivery across rural and urban deployments. At the heart of this suite is Perkant Tech’s flagship invention, Abhay Parimiti—patented in India and the US—which provides automated health assessments in under 60 seconds, making healthcare insights accessible, rapid and impactful.

By Anurag

I am a blogger with a passion for Running!...

Leave a Reply

Your email address will not be published. Required fields are marked *